Search | IOVS | ARVO Journals

Showing 1 – 20 of 158

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Forecasting glaucoma from multimodal data using deep learning models

Xiaoqin Huang; Asma Poursoroush; Yeganeh Madadi; Hina Raja; Mohammad Delsoz; Louis R. Pasquale; Michael V. Boland; Chris A Johnson; Nazlee Zebardast; Siamak Yousefi

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):374.

ARVO Annual Meeting Abstract June 2024

Histopathological evaluation of a novel titratable aqueous shunt with comparison to a commercially available aqueous shunt

Austin Nakatsuka; Catherine Johnson; Nick Mamalis; Michelle Tran; Robert Chang; Arsham Sheybani; Iqbal Ahmed

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3529.

ARVO Annual Meeting Abstract June 2023

Prediction model of visual field progression in the Ocular Hypertension Treatment Study

Mae O Gordon; Dale K Heuer; Eve J Higginbotham; Richard K Parrish; Chris A Johnson; Lei Liu; Michael A Kass

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):104.

ARVO Annual Meeting Abstract June 2023

Validation of a Novel Head-Mounted Perimeter versus the Humphrey Field Analyzer

Wisam Najdawi; Chris A Johnson; Andrew Pouw

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5496.

ARVO Annual Meeting Abstract June 2023

Predicting Visual Field Worsening with Longitudinal Optical Coherence Tomography Data Using a Gated Transformer Network

Kaihua Hou; Chris Bradley; Patrick Herbert; Chris A Johnson; Michael Wall; Pradeep Y Ramulu; Mathias Unberath; Jithin Yohannan

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):978.

ARVO Annual Meeting Abstract June 2023

Glaucoma subtyping based on visual field progression using unsupervised machine learning

Xiaoqin Huang; Asma Poursoroush; Jian Sun; Louis R Pasquale; Michael Boland; Chris A Johnson; Siamak Yousefi

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):368.

ARVO Annual Meeting Abstract June 2023

A Novel Approach to AMD Detection: Using an Augmented Reality Headset for Dark Adaptometry

Rashed Kashem; David Josue Taylor Gonzalez; Elysia Ison; Ece Turhal; Ahmed Sayed; Collins Opoku-Baah; Valeria Lopez; Catherine Johnson; Georgeana Mijares; Maria Matosas; Nadine Rady; Mary K Durbin; Michael Chen; Andrew Calman; Mohamed Abou Shousha; John McSoley

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2738.

ARVO Annual Meeting Abstract June 2023

Association Between Aging and Dark Adaptation Measured with an Augmented Reality Head-Mounted Device

David Josue Taylor Gonzalez; Nadine Rady; Rashed Kashem; Catherine Johnson; Elysia Ison; Ece Turhal; Ahmed Sayed; Collins Opoku-Baah; Mary K Durbin; Michael Chen; Maria Matosas; Georgeana Mijares; Valeria Lopez; Andrew Calman; Mohamed Abou Shousha; John McSoley

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1507.

ARVO Annual Meeting Abstract June 2022

A Comparison of Clinician and Deep Learning Performance at Detecting Visual Field Worsening

Kaihua Hou; Jasdeep Sabharwal; Patrick Herbert; Chris Bradley; Chris A Johnson; Michael Wall; Pradeep Y Ramulu; Mathias Unberath; Jithin Yohannan

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2014 – A0455.

ARVO Annual Meeting Abstract June 2022

An objective and easy-to-use glaucoma severity classification system based on artificial intelligence

Xiaoqin Huang; Fatemeh Saki; Mengyu Wang; Tobias Elze; Michael Boland; Louis Pasquale; Chris A Johnson; Siamak Yousefi

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2292.

ARVO Annual Meeting Abstract June 2022

Staging Structural Damage in Glaucoma Based on Optical Coherence Tomography

Siamak Yousefi; Xiaoqin Huang; Paolo Brusini; Chris A Johnson

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2024 – A0465.

ARVO Annual Meeting Abstract June 2022

Incidence and risk factors for recurrent visual field progression in glaucoma

Alessandro A Jammal; Tais Estrela; Chris A Johnson; Michael Wall; Felipe Medeiros

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1282 – A0422.

ARVO Annual Meeting Abstract June 2022

Convolutional Neural Network for Glaucoma detection using Compass color fundus images

CHIARA RUI; Silvia Gazzina; Giovanni Montesano; David P. Crabb; David F Garway-Heath; Francesco Oddone; Paolo Lanzetta; Paolo Brusini; Chris A Johnson; Paolo Fogagnolo; Luca M Rossetti

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2039 – A0480.

ARVO Annual Meeting Abstract June 2022

Pre- and Post-POAG Rate of Visual Field Progression in the Ocular Hypertension Treatment (OHTS) Study

Mae e Gordon; James David Brandt; Dale K Heuer; Eve J higginbotham; Richard K Parrish II; Chris A Johnson; John L Keltner; Julia Huecker; Michael A Kass

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3495.

ARVO Annual Meeting Abstract June 2022

Contrast Sensitivity Application for Augmented Reality Wearable Device

Valeria Lopez; Catherine Johnson; Nadine Rady; Georgeana Mijares; Mary K Durbin; Alexandra Nicklin, OD; Mohamed Abou Shousha

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):721 – F0449.

ARVO Annual Meeting Abstract June 2022

Impact of Corrective Lenses on the Supra-threshold Visual Field Test with Augmented Reality Headsets

Nadine Rady; Catherine Johnson; Valeria Lopez; Georgeana Mijares; Mary K Durbin; Alexandra Nicklin, OD; Mohamed Abou Shousha

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):722 – F0450.

ARVO Annual Meeting Abstract June 2022

Correlation Between SITA Fast Visual Field Strategy Measurements and Augmented Reality-Based Heru re:Vive Visual Field Strategy Measurements

Catherine Johnson; Nadine Rady; Valeria Lopez; Georgeana Mijares; Mary Durbin, PhD; Alexandra Nicklin, OD; Mohamed Abou Shousha

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1271 – A0411.

Articles October 2021

Demographic, Comorbid, and Clinical Variables Associated With Pointwise Visual Field Damage in Glaucoma: Data From the AGIS and CIGTS Clinical Trials

PDF

Brenda W. Gillespie; Leslie M. Niziol; Joshua R. Ehrlich; Chris A. Johnson; Joseph Caprioli; Paul C. VanVeldhuisen; Paul R. Lichter; David C. Musch
TAGS: comorbidity, demography, glaucoma, visual fields, hypertension, eye, diabetes mellitus, diabetes mellitus, type 2
Trans. Vis. Sci. Tech.. 2021; 10(12):28. https://doi.org/10.1167/tvst.10.12.28

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2021

Do additional testing locations improve the detection of macular perimetric defects in glaucoma?

Giovanni Montesano; Allison M McKendrick; Andrew Turpin; Paolo Brusini; Francesco Oddone; Paolo Fogagnolo; Andrea Perdicchi; Chris A Johnson; Paolo Lanzetta; Luca Mario Rossetti; David F Garway-Heath; David P. Crabb

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3485.

ARVO Annual Meeting Abstract June 2021

Detecting Glaucoma Progression using Deep Archetypal Analysis of Retinal Nerve Fiber Layer Thickness Measurements

Sidharth Mahotra; Xiaoqin Huang; Tobias Elze; Mengyu Wang; Michael V Boland; Louis Pasquale; Juleke Eugenie Anne Majoor; Koenraad Arndt Vermeer; Hans Lemij; Kouros Nouri-Mahdavi; Chris A Johnson; Siamak Yousefi

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3357.

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Forecasting glaucoma from multimodal data using deep learning models

Histopathological evaluation of a novel titratable aqueous shunt with comparison to a commercially available aqueous shunt

Prediction model of visual field progression in the Ocular Hypertension Treatment Study

Validation of a Novel Head-Mounted Perimeter versus the Humphrey Field Analyzer

Predicting Visual Field Worsening with Longitudinal Optical Coherence Tomography Data Using a Gated Transformer Network

Glaucoma subtyping based on visual field progression using unsupervised machine learning

A Novel Approach to AMD Detection: Using an Augmented Reality Headset for Dark Adaptometry

Association Between Aging and Dark Adaptation Measured with an Augmented Reality Head-Mounted Device

A Comparison of Clinician and Deep Learning Performance at Detecting Visual Field Worsening

An objective and easy-to-use glaucoma severity classification system based on artificial intelligence

Staging Structural Damage in Glaucoma Based on Optical Coherence Tomography

Incidence and risk factors for recurrent visual field progression in glaucoma

Convolutional Neural Network for Glaucoma detection using Compass color fundus images

Pre- and Post-POAG Rate of Visual Field Progression in the Ocular Hypertension Treatment (OHTS) Study

Contrast Sensitivity Application for Augmented Reality Wearable Device

Impact of Corrective Lenses on the Supra-threshold Visual Field Test with Augmented Reality Headsets

Correlation Between SITA Fast Visual Field Strategy Measurements and Augmented Reality-Based Heru re:Vive Visual Field Strategy Measurements

Demographic, Comorbid, and Clinical Variables Associated With Pointwise Visual Field Damage in Glaucoma: Data From the AGIS and CIGTS Clinical Trials

Do additional testing locations improve the detection of macular perimetric defects in glaucoma?

Detecting Glaucoma Progression using Deep Archetypal Analysis of Retinal Nerve Fiber Layer Thickness Measurements

To View More...

You must be signed into an individual account to use this feature.